Evidence map›Paper›PMID 39771468›Full record

ArticlePharmaceutics2024

Lipid Nanoparticle Formulations for the Skin Delivery of Cannabidiol.

Maria Natalia Calienni, Mirian Ana Scavone, Ana Paula Sanguinetti, Merlina Corleto, Magalí Rocío Di Meglio, Pablo Raies, Diego Sebastián Cristos, Paulo César Maffia, Jorge Montanari

Abstract read
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maria Natalia CalienniUniversidad Nacional de Hurlingham (UNAHUR), Secretaría de Investigación, Laboratorio de Nanosistemas de Aplicación Biotecnológica (LANSAB), Hurlingham 1688, Buenos Aires, Argentina.ORCID 0000-0001-8776-3307
Mirian Ana ScavoneUniversidad Nacional de Hurlingham (UNAHUR), Secretaría de Investigación, Laboratorio de Nanosistemas de Aplicación Biotecnológica (LANSAB), Hurlingham 1688, Buenos Aires, Argentina.
Ana Paula SanguinettiUniversidad Nacional de Hurlingham (UNAHUR), Secretaría de Investigación, Laboratorio de Nanosistemas de Aplicación Biotecnológica (LANSAB), Hurlingham 1688, Buenos Aires, Argentina.ORCID 0009-0002-9034-3949
Merlina CorletoConsejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad Autónoma de Buenos Aires 1425, Argentina.
Magalí Rocío Di MeglioUniversidad Nacional de Hurlingham (UNAHUR), Secretaría de Investigación, Laboratorio de Nanosistemas de Aplicación Biotecnológica (LANSAB), Hurlingham 1688, Buenos Aires, Argentina.ORCID 0009-0008-8181-1601
Pablo RaiesUniversidad Nacional de Hurlingham (UNAHUR), Secretaría Académica, Hurlingham 1688, Buenos Aires, Argentina.
Diego Sebastián CristosInstituto Tecnología de Alimentos-Centro de Investigación de Agroindustria (CIA-INTA), Hurlingham 1686, Buenos Aires, Argentina.
Paulo César MaffiaConsejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad Autónoma de Buenos Aires 1425, Argentina.ORCID 0000-0001-7423-2646
Jorge MontanariUniversidad Nacional de Hurlingham (UNAHUR), Secretaría de Investigación, Laboratorio de Nanosistemas de Aplicación Biotecnológica (LANSAB), Hurlingham 1688, Buenos Aires, Argentina.ORCID 0000-0002-9177-0240

Funding

AGENCIA NACIONAL DE PROMOCIÓN DE LA INVESTIGACIÓN, EL DESARROLLO TECNOLÓGICO Y LA INNOVACIÓN PICT-2020-SERIEA-03644COMISIÓN DE INVESTIGACIONES CIENTÍFICAS DE LA PROVINCIA DE BUENOS AIRES IDEAS PROYECTO 23-24 - (IP 2023-2024)Consejo Nacional de Investigaciones Científicas y Técnicas PIO UNAHUR - CONICET 2022-2023 29020220100001COUniversidad Nacional de Hurlingham PIO UNAHUR - CONICET 2022-2023 29020220100001COUniversidad Nacional de Hurlingham PIUNAHUR 2023 80020230100020HU
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibacterialcannabidiolnanostructured lipid carriersskinsolid lipid nanoparticles

Identifiers

PMID39771468
PMCPMC11676254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.